target mrna abundance dilutes microrna and sirna activity aaron arvey memorial sloan kettering...

31
Target mRNA abundance dilutes microRNA and siRNA activity Aaron Arvey Memorial Sloan Kettering Cancer Center MicroRNAs and Human Disease February 12th 2011 Subtitle: All Target Genes Are Sponges

Upload: amie-holmes

Post on 29-Jan-2016

215 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Target mRNA abundance dilutes microRNA and siRNA activity Aaron Arvey Memorial Sloan Kettering Cancer Center MicroRNAs and Human Disease February 12th

Target mRNA abundance dilutes microRNA and siRNA activity

Aaron ArveyMemorial Sloan Kettering Cancer Center

MicroRNAs and Human DiseaseFebruary 12th 2011

Subtitle:All Target Genes Are Sponges

Page 2: Target mRNA abundance dilutes microRNA and siRNA activity Aaron Arvey Memorial Sloan Kettering Cancer Center MicroRNAs and Human Disease February 12th

Concept: Small RNAs with

many targets downregulate each individual target to a

lesser extent

Target Concentration

Dow

nreg

ulat

ion

Page 3: Target mRNA abundance dilutes microRNA and siRNA activity Aaron Arvey Memorial Sloan Kettering Cancer Center MicroRNAs and Human Disease February 12th

microRNAs induce different amounts of downregulation

QuickTime™ and a decompressor

are needed to see this picture.

BigShift

LittleShift

Data from Grimson et. al., 2007

Page 4: Target mRNA abundance dilutes microRNA and siRNA activity Aaron Arvey Memorial Sloan Kettering Cancer Center MicroRNAs and Human Disease February 12th

Meta-analysis of transfection studies

• 178 transfection experiments in HeLa and HCT116 cell lines– 61 miRNA-mimics (Lim 2005, Grimson 2007, He 2007, Linsley 2007,

Selbach 2008)– 98 siRNA (Kittler 2007, Anderson 2008, Jackson 2006, Schwarz 2006)– 19 chimeras (Lim, 2005, Anderson 2008)

• Microarray assay post-transfection

• RNA-Seq to quantify mRNA target abundance (Morin 2008)

Page 5: Target mRNA abundance dilutes microRNA and siRNA activity Aaron Arvey Memorial Sloan Kettering Cancer Center MicroRNAs and Human Disease February 12th

QuickTime™ and a decompressor

are needed to see this picture.

QuickTime™ and a decompressor

are needed to see this picture.

Off-Target Concentration

Quic

kTim

e™

and

a d

ecom

pre

sso

rare

nee

ded

to

see

th

is p

ictu

re.

Prim

ary

Tar

get

Dow

nreg

ulat

ion

QuickTime™ and a decompressor

are needed to see this picture.

Target ConcentrationM

ean

Tar

get

Dow

nreg

ulat

ion

Average downregulation is correlated with

target concentration

A single target is effected

by all other targets

Sod1Mapk14GapdhPpib

Page 6: Target mRNA abundance dilutes microRNA and siRNA activity Aaron Arvey Memorial Sloan Kettering Cancer Center MicroRNAs and Human Disease February 12th

Pairwise examples Examples of

differential regulation on shared targets

QuickTime™ and a decompressor

are needed to see this picture.

Target Concentration

Mea

n T

arge

t D

ownr

egul

atio

nQuickTime™ and a

decompressorare needed to see this picture.

QuickTime™ and a decompressor

are needed to see this picture.

Page 7: Target mRNA abundance dilutes microRNA and siRNA activity Aaron Arvey Memorial Sloan Kettering Cancer Center MicroRNAs and Human Disease February 12th

Kinetics Questions

• Were we guaranteed to find this result?– Depends on dynamic range of kinetic relationship– Degradation is a function of speed, time, and concentration– We have only considered downregulation and concentration

• Downregulation is defined as the ratio:

• Result depends on the velocity of degradation v

logxTx0

⎝ ⎜

⎠ ⎟= log

x0 − v

x0

⎝ ⎜

⎠ ⎟

Page 8: Target mRNA abundance dilutes microRNA and siRNA activity Aaron Arvey Memorial Sloan Kettering Cancer Center MicroRNAs and Human Disease February 12th

Velocity is correlated with target abundance and follows Michaelis-Menten kinetics

QuickTime™ and a decompressor

are needed to see this picture.

Concentration of Predicted Targets (RPN)

Vel

ocity

(a.

u.)

Target Concentration

Previous work by Haley & Zamore (2004) suggested similar kinetics in extract usingsingle competitor target

Page 9: Target mRNA abundance dilutes microRNA and siRNA activity Aaron Arvey Memorial Sloan Kettering Cancer Center MicroRNAs and Human Disease February 12th

ERIK’S SLIDEPoster #245

1778 siRNA transfection experiments

AU-rich constructssupport turnover

as important mechanism

AREsE

ffic

acy

Page 10: Target mRNA abundance dilutes microRNA and siRNA activity Aaron Arvey Memorial Sloan Kettering Cancer Center MicroRNAs and Human Disease February 12th

Recent Literature

QuickTime™ and a decompressor

are needed to see this picture.

Cancer:PTEN pseudogene 1 (PTENP1) regulates cell cycle by way of PTEN

Poliseno et al, 2010

Cazalla et al, 2010Virus & Host:Herpesvirus transcriptsdownregulate host microRNAs

Page 11: Target mRNA abundance dilutes microRNA and siRNA activity Aaron Arvey Memorial Sloan Kettering Cancer Center MicroRNAs and Human Disease February 12th

Questions

QuickTime™ and a decompressor

are needed to see this picture.

Erik LarssonPoster #245

Chris Sander

Christina Leslie

Debbie Marks

QuickTime™ and a decompressor

are needed to see this picture.

QuickTime™ and a decompressor

are needed to see this picture.Poster #105

Anders JacobsenPoster #232

QuickTime™ and a decompressor

are needed to see this picture.

Consequences

• Each microRNA is unique in its ability to downregulate targets

• Each cellular context presents different ‘sponges’

• siRNA design criterion

• Evolutionary constraints

QuickTime™ and a decompressor

are needed to see this picture.

Page 12: Target mRNA abundance dilutes microRNA and siRNA activity Aaron Arvey Memorial Sloan Kettering Cancer Center MicroRNAs and Human Disease February 12th

QuickTime™ and a decompressor

are needed to see this picture.

Pairwise examplesQuickTime™ and a decompressor

are needed to see this picture.

• Smad5 downregulation– miR-155: -1.29– miR-106: -0.1

• Target abundance– miR-155: 142– miR-106: 315

• Differences– Downregulation: 1.19– Abundance: 173

Page 13: Target mRNA abundance dilutes microRNA and siRNA activity Aaron Arvey Memorial Sloan Kettering Cancer Center MicroRNAs and Human Disease February 12th

Consequences

• Each microRNA is quantitatively unique– Definition of target should perhaps be different for different

microRNAs– Improve target prediction methods

• Evolutionary constraints– Possibility 1: anti-targets (mRNA transcripts that ‘avoid’ being

co-expressed with microRNA) enable the cell to avoid high target concentration

– Possibility 2: microRNA expression increases when target mRNAs increase, dosage compensation

Page 14: Target mRNA abundance dilutes microRNA and siRNA activity Aaron Arvey Memorial Sloan Kettering Cancer Center MicroRNAs and Human Disease February 12th

Consequences

• Limits knockdown of primary target– May limit drug efficacy, especially in small concentration– May limit functional genomic screens

• Limits the knockdown of off-targets– Increase in off-targets may actually decrease toxicity

(Anderson et al, 2008)

Page 15: Target mRNA abundance dilutes microRNA and siRNA activity Aaron Arvey Memorial Sloan Kettering Cancer Center MicroRNAs and Human Disease February 12th
Page 16: Target mRNA abundance dilutes microRNA and siRNA activity Aaron Arvey Memorial Sloan Kettering Cancer Center MicroRNAs and Human Disease February 12th

Recent Literature

Environmental Response:Non-coding RNA regulates phosphate starvation response(Franco Zorrilla et al, 2007)

QuickTime™ and a decompressor

are needed to see this picture.

Page 17: Target mRNA abundance dilutes microRNA and siRNA activity Aaron Arvey Memorial Sloan Kettering Cancer Center MicroRNAs and Human Disease February 12th

Background: RISC Kinetics

• Multi-turnover enzyme– Single loaded RISC is able to degrade many mRNA

transcripts (Hutvágner & Zamore, 2002)

• RISC is saturated with small RNA upon transfection (Khan et al, 2009)

• Degradation in lysate is very fast (Haley & Zamore, 2004)

[RISC] + [target] [RISC+target] [RISC] + [product]

Page 18: Target mRNA abundance dilutes microRNA and siRNA activity Aaron Arvey Memorial Sloan Kettering Cancer Center MicroRNAs and Human Disease February 12th

QuickTime™ and a decompressor

are needed to see this picture.

Haley & Zamore (2004)

Kinetics in drosophila lysate

Pro

duct

(nM

)

Background: RISC Kinetics

• Degradation kinetics depend on target concentration

• 1nM RISC in lysate– Slope of line is velocity– Transcripts degraded at rate

of 72-300nM transcript/day

• Target concentration in cell is likely to be in the range 1-60nM

• 72nM > 60nM– Ignores transcriptional rate– Ignores cellular context– Ignores localization

Target Concentration (nM)

Cha

nge

in m

olec

ules

(vel

ocity

nM

/min

)

1nM

5nM

20nM

60nM

Page 19: Target mRNA abundance dilutes microRNA and siRNA activity Aaron Arvey Memorial Sloan Kettering Cancer Center MicroRNAs and Human Disease February 12th

Past Evidence: Dilution In Solution

QuickTime™ and a decompressor

are needed to see this picture.

Haley & Zamore (2004)

Page 20: Target mRNA abundance dilutes microRNA and siRNA activity Aaron Arvey Memorial Sloan Kettering Cancer Center MicroRNAs and Human Disease February 12th

We control for several alternative explanations

• A+U content– Not correlated

• 3’ UTR length– Correlated, controllable by shared targets

• Expression of individual targets– Correlated, controllable by shared targets

Page 21: Target mRNA abundance dilutes microRNA and siRNA activity Aaron Arvey Memorial Sloan Kettering Cancer Center MicroRNAs and Human Disease February 12th
Page 22: Target mRNA abundance dilutes microRNA and siRNA activity Aaron Arvey Memorial Sloan Kettering Cancer Center MicroRNAs and Human Disease February 12th

3’ UTR Length is correlated with expression level

Page 23: Target mRNA abundance dilutes microRNA and siRNA activity Aaron Arvey Memorial Sloan Kettering Cancer Center MicroRNAs and Human Disease February 12th

Individual target abundance is correlated with downregulation

Page 24: Target mRNA abundance dilutes microRNA and siRNA activity Aaron Arvey Memorial Sloan Kettering Cancer Center MicroRNAs and Human Disease February 12th

Caveats of shared-target analysis

• False positive rate may increase sub-linearly– If false positive rate increases with number of predicted

targets, becomes harder to control– The siRNA analysis completely controls for this (since

there is only a single primary target!)

• Length of UTR is 2x normal length in shared targets– Normal: 1167nt– Shared target: 2041nt– Longer 3’ UTR may lead to increased downregulation,

though this would not give preference for a specific microRNA

Page 25: Target mRNA abundance dilutes microRNA and siRNA activity Aaron Arvey Memorial Sloan Kettering Cancer Center MicroRNAs and Human Disease February 12th

Methods: Target Prediction

QuickTime™ and a decompressor

are needed to see this picture.

QuickTime™ and a decompressor

are needed to see this picture.

QuickTime™ and a decompressor

are needed to see this picture.

Page 26: Target mRNA abundance dilutes microRNA and siRNA activity Aaron Arvey Memorial Sloan Kettering Cancer Center MicroRNAs and Human Disease February 12th

Methods: Target Abundance

QuickTime™ and a decompressor

are needed to see this picture.QuickTime™ and a

decompressorare needed to see this picture.

Page 27: Target mRNA abundance dilutes microRNA and siRNA activity Aaron Arvey Memorial Sloan Kettering Cancer Center MicroRNAs and Human Disease February 12th

Methods: DownregulationTime Course

QuickTime™ and a decompressor

are needed to see this picture.QuickTime™ and a

decompressorare needed to see this picture.

Page 28: Target mRNA abundance dilutes microRNA and siRNA activity Aaron Arvey Memorial Sloan Kettering Cancer Center MicroRNAs and Human Disease February 12th

Correlation between siRNA off-target abundance and primary target downregulation

QuickTime™ and a decompressor

are needed to see this picture.

Off Target Abundance

Log2

Exp

ress

ion

Rat

ioof

prim

ary

targ

et

Page 29: Target mRNA abundance dilutes microRNA and siRNA activity Aaron Arvey Memorial Sloan Kettering Cancer Center MicroRNAs and Human Disease February 12th

Past Evidence - Toxicity

Anderson et al (2008)

Page 30: Target mRNA abundance dilutes microRNA and siRNA activity Aaron Arvey Memorial Sloan Kettering Cancer Center MicroRNAs and Human Disease February 12th

Past Evidence - Dilution In Cells

Ebert et al 2007

Page 31: Target mRNA abundance dilutes microRNA and siRNA activity Aaron Arvey Memorial Sloan Kettering Cancer Center MicroRNAs and Human Disease February 12th

Normalization

QuickTime™ and a decompressor

are needed to see this picture.